SAN DIEGO, CA, Aug. 11, 2011 -- A lawsuit filed against the Metropolitan Water District of Southern California alleges that the utility selected and utilized an unapproved drug to fulfill its fluoridation program.
The case, Foli v. Metropolitan Water District of Southern California, filed by California attorneys at Blumenthal, Nordrehaug & Bhowmik, alleges that MWD selected and delivered a hydrofluosilicic acid drug through their water system that had not had a toxicological study performed on it until 2010.
Kyle Nordrehaug, attorney for the plaintiffs, said the case "does not challenge the public policy of fluoridation" and the plaintiffs are not seeking any monetary award for any physical harm. They maintain, however, that the drug was never approved by FDA for safety and effectiveness for the purpose of treating or preventing dental disease.
###
